Targeting Inflammation to Reduce Cardiovascular Disease Risk: a Realistic Clinical Prospect?

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2017 Apr 15

PMID 28409825

Citations 63

Authors

Paul Welsh

Gianluca Grassia

Shani Botha

Naveed Sattar

Pasquale Maffia

Affiliations

Soon will be listed here.

Abstract

Linked Articles: This article is part of a themed section on Targeting Inflammation to Reduce Cardiovascular Disease Risk. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.22/issuetoc and http://onlinelibrary.wiley.com/doi/10.1111/bcp.v82.4/issuetoc.

Citing Articles

Device-Measured Physical Activity, Sedentary Behaviour and Risk of Chronic Kidney Diseases Across Levels of Grip Strength.

He Y, Wang J, Zhang W, Chen X, Wu Q, Li Y J Cachexia Sarcopenia Muscle. 2025; 16(1):e13726.

PMID: 39957059 PMC: 11830631. DOI: 10.1002/jcsm.13726.

The two coin sides of bacterial extracellular membrane nanovesicles: atherosclerosis trigger or remedy.

Lusta K, Churov A, Beloyartsev D, Golovyuk A, Lee A, Sukhorukov V Discov Nano. 2024; 19(1):179.

PMID: 39532781 PMC: 11557815. DOI: 10.1186/s11671-024-04149-8.

Accelerometer-measured physical activity, sedentary behavior, and incidence of macrovascular and microvascular events in individuals with type 2 diabetes mellitus and prediabetes.

Liang Y, He Y, Huang P, Feng H, Li H, Ai S J Sport Health Sci. 2024; 14:100973.

PMID: 39214513 PMC: 11863271. DOI: 10.1016/j.jshs.2024.100973.

Cell-cell communication: new insights and clinical implications.

Su J, Song Y, Zhu Z, Huang X, Fan J, Qiao J Signal Transduct Target Ther. 2024; 9(1):196.

PMID: 39107318 PMC: 11382761. DOI: 10.1038/s41392-024-01888-z.

Whole body vibration elicits differential immune and metabolic responses in obese and normal weight individuals.

Blanks A, Rodriguez-Miguelez P, Looney J, Tucker M, Jeong J, Thomas J Brain Behav Immun Health. 2024; 1:100011.

PMID: 38377415 PMC: 8474538. DOI: 10.1016/j.bbih.2019.100011.

References

Talmud P, Holmes M . Deciphering the Causal Role of sPLA2s and Lp-PLA2 in Coronary Heart Disease. Arterioscler Thromb Vasc Biol. 2015; 35(11):2281-9. DOI: 10.1161/ATVBAHA.115.305234. View

Alexander S, Fabbro D, Kelly E, Marrion N, Peters J, Benson H . The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol. 2015; 172(24):6024-109. PMC: 4718211. DOI: 10.1111/bph.13354. View

Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T . Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ. 2011; 342:d548. PMC: 3039696. DOI: 10.1136/bmj.d548. View

Myung S, Ju W, Cho B, Oh S, Park S, Koo B . Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ. 2013; 346:f10. PMC: 3548618. DOI: 10.1136/bmj.f10. View

Kwak B, Mulhaupt F, Myit S, Mach F . Statins as a newly recognized type of immunomodulator. Nat Med. 2000; 6(12):1399-402. DOI: 10.1038/82219. View

Maffia P, Zinselmeyer B, Ialenti A, Kennedy S, Baker A, McInnes I . Images in cardiovascular medicine. Multiphoton microscopy for 3-dimensional imaging of lymphocyte recruitment into apolipoprotein-E-deficient mouse carotid artery. Circulation. 2007; 115(11):e326-8. DOI: 10.1161/CIRCULATIONAHA.106.658492. View

Ohta H, Wada H, Niwa T, Kirii H, Iwamoto N, Fujii H . Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis. 2005; 180(1):11-7. DOI: 10.1016/j.atherosclerosis.2004.11.016. View

Fulgoni 3rd V, Keast D, Bailey R, Dwyer J . Foods, fortificants, and supplements: Where do Americans get their nutrients?. J Nutr. 2011; 141(10):1847-54. PMC: 3174857. DOI: 10.3945/jn.111.142257. View

Libby P, Hansson G . Inflammation and immunity in diseases of the arterial tree: players and layers. Circ Res. 2015; 116(2):307-11. PMC: 4299915. DOI: 10.1161/CIRCRESAHA.116.301313. View

10.

Liao J, Laufs U . Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005; 45:89-118. PMC: 2694580. DOI: 10.1146/annurev.pharmtox.45.120403.095748. View

11.

Ettehad D, Emdin C, Kiran A, Anderson S, Callender T, Emberson J . Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016; 387(10022):957-967. DOI: 10.1016/S0140-6736(15)01225-8. View

12.

Cannon C, Cariou B, Blom D, McKenney J, Lorenzato C, Pordy R . Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial. Eur Heart J. 2015; 36(19):1186-94. PMC: 4430683. DOI: 10.1093/eurheartj/ehv028. View

13.

PAULING L . The significance of the evidence about ascorbic acid and the common cold. Proc Natl Acad Sci U S A. 1971; 68(11):2678-81. PMC: 389499. DOI: 10.1073/pnas.68.11.2678. View

14.

McInnes I, Thompson L, Giles J, Bathon J, Salmon J, Beaulieu A . Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Ann Rheum Dis. 2013; 74(4):694-702. PMC: 4392313. DOI: 10.1136/annrheumdis-2013-204345. View

15.

Srikakulapu P, Hu D, Yin C, Mohanta S, Bontha S, Peng L . Artery Tertiary Lymphoid Organs Control Multilayered Territorialized Atherosclerosis B-Cell Responses in Aged ApoE-/- Mice. Arterioscler Thromb Vasc Biol. 2016; 36(6):1174-85. PMC: 4894775. DOI: 10.1161/ATVBAHA.115.306983. View

16.

Agca R, Heslinga S, Rollefstad S, Heslinga M, McInnes I, Peters M . EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2016; 76(1):17-28. DOI: 10.1136/annrheumdis-2016-209775. View

17.

Ye Y, Li J, Yuan Z . Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One. 2013; 8(2):e56803. PMC: 3577664. DOI: 10.1371/journal.pone.0056803. View

18.

Weng T, Yang Y, Lin S, Tai S . A systematic review and meta-analysis on the therapeutic equivalence of statins. J Clin Pharm Ther. 2010; 35(2):139-51. DOI: 10.1111/j.1365-2710.2009.01085.x. View

19.

WILLIS G . An experimental study of intimal ground substance in atherosclerosis. Can Med Assoc J. 1953; 69(1):17-22. PMC: 1822858. View

20.

Casas J, Ninio E, Panayiotou A, Palmen J, Cooper J, Ricketts S . PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry. Circulation. 2010; 121(21):2284-93. PMC: 3377948. DOI: 10.1161/CIRCULATIONAHA.109.923383. View